All In MedTech

FDA Clearance Tracker · P170002

RHA 2, RHA 3, RHA 4

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Oct 19, 2017 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Oct 19, 2017

Approved

Time to decision

275 days

Received Jan 17, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P170002
Device name
RHA 2, RHA 3, RHA 4
Applicant
Teoxane S.A.
Applicant location
Geneva
Received
Jan 17, 2017
Decided
Oct 19, 2017
Decision
Approved
Supplements
55 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LMH

FDA's approval statement

As written in FDA's record.

Approval for the RH-2. The RHA 2 is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older. RHA 3 is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older. RHA 4 is indicated for injection into the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LMH. The earliest in FDA's data is P800022, decided Jul 22, 1981.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Teoxane S.A.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.